TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment of Feeding Tolerance in Infants Fed Cow Milk Formula
Brief Summary: To compare the number of infants who discontinue from study formula due to formula intolerance as documented by the investigator.

Hypothesize there will be no difference between formula groups.


Options:
A: Arm Label: A highly hydrolyzed casein formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: A highly hydrolyzed formula | Arm Label: A conventiona cow's milk based formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: A regular cow's milk based formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A highly hydrolyzed formula; Assigned to Arm(s): A highly hydrolyzed casein formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A regular cow's milk based formula; Assigned to Arm(s): A conventiona cow's milk based formula
B: Arm Label: extensively hydrolyzed casein formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: dietary intervention | Arm Label: cow's milk based infant formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: dietary intervention | Intervention Type: DIETARY_SUPPLEMENT; Name: dietary intervention; Assigned to Arm(s): cow's milk based infant formula, extensively hydrolyzed casein formula
C: Arm Label: Hydrolysed infant formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Hydrolysed infant formula | Arm Label: Nonhydrolysed infant formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Nonhydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Hydrolysed infant formula; Assigned to Arm(s): Hydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Nonhydrolysed infant formula; Assigned to Arm(s): Nonhydrolysed infant formula
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Enfamil LIPIL with iron | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Good Start Supreme with DHA and ARA | Intervention Type: OTHER; Name: Enfamil LIPIL with iron; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Good Start Supreme with DHA and ARA; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment of Feeding Tolerance in Infants Fed Cow Milk Formula
Brief Summary: To compare the number of infants who discontinue from study formula due to formula intolerance as documented by the investigator.

Hypothesize there will be no difference between formula groups.


Options:
A: Arm Label: A highly hydrolyzed casein formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: A highly hydrolyzed formula | Arm Label: A conventiona cow's milk based formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: A regular cow's milk based formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A highly hydrolyzed formula; Assigned to Arm(s): A highly hydrolyzed casein formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A regular cow's milk based formula; Assigned to Arm(s): A conventiona cow's milk based formula
B: Arm Label: Hydrolysed infant formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Hydrolysed infant formula | Arm Label: Nonhydrolysed infant formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Nonhydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Hydrolysed infant formula; Assigned to Arm(s): Hydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Nonhydrolysed infant formula; Assigned to Arm(s): Nonhydrolysed infant formula
C: Arm Label: extensively hydrolyzed casein formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: dietary intervention | Arm Label: cow's milk based infant formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: dietary intervention | Intervention Type: DIETARY_SUPPLEMENT; Name: dietary intervention; Assigned to Arm(s): cow's milk based infant formula, extensively hydrolyzed casein formula
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Enfamil LIPIL with iron | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Good Start Supreme with DHA and ARA | Intervention Type: OTHER; Name: Enfamil LIPIL with iron; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Good Start Supreme with DHA and ARA; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment of Feeding Tolerance in Infants Fed Cow Milk Formula
Brief Summary: To compare the number of infants who discontinue from study formula due to formula intolerance as documented by the investigator.

Hypothesize there will be no difference between formula groups.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Enfamil LIPIL with iron | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Good Start Supreme with DHA and ARA | Intervention Type: OTHER; Name: Enfamil LIPIL with iron; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Good Start Supreme with DHA and ARA; Assigned to Arm(s): 2
B: Arm Label: A highly hydrolyzed casein formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: A highly hydrolyzed formula | Arm Label: A conventiona cow's milk based formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: A regular cow's milk based formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A highly hydrolyzed formula; Assigned to Arm(s): A highly hydrolyzed casein formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A regular cow's milk based formula; Assigned to Arm(s): A conventiona cow's milk based formula
C: Arm Label: Group EEEEEEE; Type: ACTIVE_COMPARATOR; Interventions: Other: Enfamil, milk-based formula | Arm Label: Group ENEEEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group EENEEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group EEENEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group ENNNEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group NNNNNNN; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Intervention Type: OTHER; Name: Nutramigen (Flavor and Type of Infant Formula); Assigned to Arm(s): Group EEENEEE, Group EENEEEE, Group ENEEEEE, Group ENNNEEE, Group NNNNNNN | Intervention Type: OTHER; Name: Enfamil, milk-based formula; Assigned to Arm(s): Group EEEEEEE
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: infant formula | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: infant formula | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Other: infant formula | Intervention Type: OTHER; Name: infant formula; Assigned to Arm(s): 1, 2, 3

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Dosis of Vitamin D as Treatment for COPD.
Brief Summary: This project aims to explore the relationship between Vitamin D deficiency and COPD progression via a prospective randomized placebo-controlled study. For this purpose, study was powered to 120 patients hospitalized with an exacerbation of COPD randomly assigned to a monthly oral dose of Vitamin D versus placebo. Taking into account dropouts, 182 patients are randomized during the course of the study


Options:
A: Intervention Type: DRUG; Name: cholecalciferol; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Physiotherapy; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: D-cure | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: D-cure; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: Calcitriol; Type: EXPERIMENTAL; Interventions: Drug: Calcitriol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Calcitriol | Intervention Type: DRUG; Name: Calcitriol; Assigned to Arm(s): Calcitriol, placebo
D: Arm Label: vitamin D oil; Type: EXPERIMENTAL; Interventions: Dietary Supplement: vitamin D | Arm Label: placebo oil; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin D; Assigned to Arm(s): placebo oil, vitamin D oil

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Dosis of Vitamin D as Treatment for COPD.
Brief Summary: This project aims to explore the relationship between Vitamin D deficiency and COPD progression via a prospective randomized placebo-controlled study. For this purpose, study was powered to 120 patients hospitalized with an exacerbation of COPD randomly assigned to a monthly oral dose of Vitamin D versus placebo. Taking into account dropouts, 182 patients are randomized during the course of the study


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: daily vitamin D supplement, Other: Placebo | Arm Label: Vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D, Dietary Supplement: daily vitamin D supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): Vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: daily vitamin D supplement; Assigned to Arm(s): Placebo, Vitamin D | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: D-cure | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: D-cure; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: 2000 IU per day vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3 - Cholecalciferol 2000 IU | Arm Label: 400 IU per day vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D - Cholecalciferol 400 IU | Intervention Type: DRUG; Name: Vitamin D - Cholecalciferol 400 IU; Assigned to Arm(s): 400 IU per day vitamin D | Intervention Type: DRUG; Name: Vitamin D3 - Cholecalciferol 2000 IU; Assigned to Arm(s): 2000 IU per day vitamin D
D: Arm Label: Vigantol oil; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol | Arm Label: Miglyol oil; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Miglyol oil | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol; Assigned to Arm(s): Vigantol oil | Intervention Type: DIETARY_SUPPLEMENT; Name: Miglyol oil; Assigned to Arm(s): Miglyol oil

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study to Examine Sleep and Fatigue in Pediatric Brain Tumor Patients Hospitalized for High Dose Chemotherapy
Brief Summary: The purpose of this pilot study is to determine if patients randomized to a hospital sleep environment intervention would have improved sleep quality and reduced fatigue as compared to the patients not receiving the intervention (standard care).


Options:
A: Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Other: Music Therapy | Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Music Therapy; Assigned to Arm(s): Interventional
B: Arm Label: Comfort Care; Type: EXPERIMENTAL; Interventions: Other: Comfort Care | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Comfort Care; Assigned to Arm(s): Comfort Care | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual Care
C: Arm Label: Acupuncture; Type: EXPERIMENTAL; Interventions: Device: acupuncture | Arm Label: Sham Acupuncture; Type: SHAM_COMPARATOR; Interventions: Device: sham acupuncture | Intervention Type: DEVICE; Name: acupuncture; Assigned to Arm(s): Acupuncture | Intervention Type: DEVICE; Name: sham acupuncture; Assigned to Arm(s): Sham Acupuncture
D: Arm Label: Intervention; Type: OTHER; Interventions: Other: Sleep Environment Intervention | Arm Label: Standard Care; Type: OTHER; Interventions: Other: Normal Hospital Environment | Intervention Type: OTHER; Name: Sleep Environment Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Normal Hospital Environment; Assigned to Arm(s): Standard Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke
Brief Summary: The aim of the study is to evaluate the functional recovery in two groups of primary stroke patients presenting with moderate/severe disability over a six month period through the implementation of a randomised controlled trial. The first group or the experimental group will receive routine therapy and additional lower limb exercise therapy in the form of family assisted exercises. The second group or the control group will receive routine therapy with no additional formal input from their family members. A secondary aim of the project is to evaluate the impact of the FAME programme on the person with stroke and the individual (s) assisting in the delivery of exercises.


Options:
A: Arm Label: Self-Directed Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-directed program | Arm Label: Stroke Support Person; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Timing it Right Stroke Family Support Person Intervention | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Timing it Right Stroke Family Support Person Intervention; Assigned to Arm(s): Stroke Support Person | Intervention Type: BEHAVIORAL; Name: Self-directed program; Assigned to Arm(s): Self-Directed Program
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Family Mediated Exercise Therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Family Mediated Exercise Therapy; Assigned to Arm(s): 1
C: Arm Label: mod. Constraint-Induced Movement Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: mod. Constraint-Induced Movement Therapy | Arm Label: Therapy as usual; Type: OTHER; Interventions: Other: Therapy as usual | Intervention Type: BEHAVIORAL; Name: mod. Constraint-Induced Movement Therapy; Assigned to Arm(s): mod. Constraint-Induced Movement Therapy | Intervention Type: OTHER; Name: Therapy as usual; Assigned to Arm(s): Therapy as usual
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Tele-Rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Tele-rehabilitation | Intervention Type: OTHER; Name: Tele-rehabilitation; Assigned to Arm(s): Tele-Rehabilitation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TRY FIRST: A 12-Week, Randomized, Open-Label Trial of Duloxetine Versus Generic SSRIs in the Treatment of a Severe Depressive Episode
Brief Summary: The purpose of this study is to compare duloxetine with other antidepressants in the treatment of severe depression.


Options:
A: Arm Label: Workcoping and IPS; Type: EXPERIMENTAL; Interventions: Behavioral: Workcoping and IPS | Arm Label: Ordinary care by GP or NAV; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ordinary care by GP or NAV | Intervention Type: BEHAVIORAL; Name: Workcoping and IPS; Assigned to Arm(s): Workcoping and IPS | Intervention Type: BEHAVIORAL; Name: Ordinary care by GP or NAV; Assigned to Arm(s): Ordinary care by GP or NAV
B: Arm Label: WHI; Type: EXPERIMENTAL; Interventions: Behavioral: Work and Health Initiative | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Medical or Behavioral Intervention | Intervention Type: BEHAVIORAL; Name: Work and Health Initiative; Assigned to Arm(s): WHI | Intervention Type: BEHAVIORAL; Name: Usual Medical or Behavioral Intervention; Assigned to Arm(s): Usual Care
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: OPC-34712, Drug: ADT | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: ADT | Intervention Type: DRUG; Name: OPC-34712; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: ADT; Assigned to Arm(s): 1, 2
D: Arm Label: duloxetine; Type: EXPERIMENTAL; Interventions: Drug: duloxetine | Arm Label: citalopram; Type: ACTIVE_COMPARATOR; Interventions: Drug: citalopram | Arm Label: fluoxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: fluoxetine | Arm Label: paroxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: paroxetine | Arm Label: sertraline; Type: ACTIVE_COMPARATOR; Interventions: Drug: sertraline | Intervention Type: DRUG; Name: duloxetine; Assigned to Arm(s): duloxetine | Intervention Type: DRUG; Name: fluoxetine; Assigned to Arm(s): fluoxetine | Intervention Type: DRUG; Name: citalopram; Assigned to Arm(s): citalopram | Intervention Type: DRUG; Name: paroxetine; Assigned to Arm(s): paroxetine | Intervention Type: DRUG; Name: sertraline; Assigned to Arm(s): sertraline

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TRY FIRST: A 12-Week, Randomized, Open-Label Trial of Duloxetine Versus Generic SSRIs in the Treatment of a Severe Depressive Episode
Brief Summary: The purpose of this study is to compare duloxetine with other antidepressants in the treatment of severe depression.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vortioxetine: 2.5 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Vortioxetine: 5 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Vortioxetine: 10 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Duloxetine: 60 mg; Type: OTHER; Interventions: Drug: Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine: 2.5 mg | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine: 5 mg | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine: 10 mg | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine: 60 mg
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vortioxetine 5 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Duloxetine 60 mg; Type: OTHER; Interventions: Drug: Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine 5 mg | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine 60 mg
C: Intervention Type: DRUG; Name: Quetiapine fumarate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): N/A
D: Arm Label: duloxetine; Type: EXPERIMENTAL; Interventions: Drug: duloxetine | Arm Label: citalopram; Type: ACTIVE_COMPARATOR; Interventions: Drug: citalopram | Arm Label: fluoxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: fluoxetine | Arm Label: paroxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: paroxetine | Arm Label: sertraline; Type: ACTIVE_COMPARATOR; Interventions: Drug: sertraline | Intervention Type: DRUG; Name: duloxetine; Assigned to Arm(s): duloxetine | Intervention Type: DRUG; Name: fluoxetine; Assigned to Arm(s): fluoxetine | Intervention Type: DRUG; Name: citalopram; Assigned to Arm(s): citalopram | Intervention Type: DRUG; Name: paroxetine; Assigned to Arm(s): paroxetine | Intervention Type: DRUG; Name: sertraline; Assigned to Arm(s): sertraline

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TRY FIRST: A 12-Week, Randomized, Open-Label Trial of Duloxetine Versus Generic SSRIs in the Treatment of a Severe Depressive Episode
Brief Summary: The purpose of this study is to compare duloxetine with other antidepressants in the treatment of severe depression.


Options:
A: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Citalopram (Celexa) | Intervention Type: DRUG; Name: Citalopram (Celexa); Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 1
B: Arm Label: duloxetine; Type: EXPERIMENTAL; Interventions: Drug: duloxetine | Arm Label: citalopram; Type: ACTIVE_COMPARATOR; Interventions: Drug: citalopram | Arm Label: fluoxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: fluoxetine | Arm Label: paroxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: paroxetine | Arm Label: sertraline; Type: ACTIVE_COMPARATOR; Interventions: Drug: sertraline | Intervention Type: DRUG; Name: duloxetine; Assigned to Arm(s): duloxetine | Intervention Type: DRUG; Name: fluoxetine; Assigned to Arm(s): fluoxetine | Intervention Type: DRUG; Name: citalopram; Assigned to Arm(s): citalopram | Intervention Type: DRUG; Name: paroxetine; Assigned to Arm(s): paroxetine | Intervention Type: DRUG; Name: sertraline; Assigned to Arm(s): sertraline
C: Arm Label: Escitalopram; Type: N/A; Interventions: N/A | Arm Label: Bupropion XL; Type: N/A; Interventions: N/A | Arm Label: Combination Therapy; Type: N/A; Interventions: N/A
D: Arm Label: 1 Problem Solving Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Problem Solving Therapy | Arm Label: 2. Escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: 3 Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BEHAVIORAL; Name: Problem Solving Therapy; Assigned to Arm(s): 1 Problem Solving Therapy | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): 2. Escitalopram | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): 3 Placebo

Answer: B